论文信息 - 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial. - 字舞流文

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

P. Teirstein | G. Stone | S. Ellis | A. Kini | S. Marx | J. Popma | D. Kereiakes | C. Simonton | R. Caputo | D. Rizik | Zhen Zhang | C. Metzger | R. McGreevy | M. Litt | A. Kabour